After winning injectable device contract with global pharma firm
Tech Group Europe, a medical device manufacturer based in Mulhuddart, Dublin, Ireland serving the pharmaceutical and medical industries, is expanding its Dublin manufacturing and development centre by approximately 1,200m2 as the result of winning a 'significant contract' with a leading global pharmaceutical firm. Tech Group Europe is a subsidiary of West Pharmaceutical Services, based in Exton, PA, US.
The project, involving the manufacture, assembly and decoration of a complex injectable device for the diabetes market, will go into full-scale production next year. The device will be shipped to the customer’s European filling site for final assembly.
'This expansion reinforces the commitment to developing the Dublin capability as part of an ongoing long-term investment plan,' said Don O’Callaghan, Vice President and General Manager of Tech Group Europe.
He added that this first phase of the expansion strengthens West’s position as a leading manufacturer of complex medical devices for the pharmaceutical market.
Tech Group Europe, established in Ireland in 1998, supplies engineering and manufacturing services for complex drug delivery devices and diagnostic solutions for the pharmaceutical and healthcare sectors.
West manufactures components for insulin pens and glucose monitoring systems at facilities in Arizona. In addition, the firm makes plungers and lined seals for insulin pen cartridges from facilities in Denmark, Germany and the US.